PEG10 抗体
(Paternally Expressed 10 (PEG10))
This is a paternally expressed imprinted gene that encodes transcripts containing two overlapping open reading frames (ORFs), RF1 and RF1/RF2, as well as retroviral-like slippage and pseudoknot elements, which can induce a -1 nucleotide frame-shift. ORF1 encodes a shorter isoform with a CCHC-type zinc finger motif containing a sequence characteristic of gag proteins of most retroviruses and some retrotransposons. The longer isoform is the result of -1 translational frame-shifting leading to translation of a gag/pol-like protein combining RF1 and RF2. It contains the active-site consensus sequence of the protease domain of pol proteins. Additional isoforms resulting from alternatively spliced transcript variants, as well as from use of upstream non-AUG (CUG) start codon, have been reported for this gene. Increased expression of this gene is associated with hepatocellular carcinomas. [provided by RefSeq, May 2010].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| PEG10 抗体 (AA 301-400) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 301-400) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-30) (PE) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-30) (APC) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-30) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-30) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-30) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-30) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-30) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-325) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PEG10 抗体 (AA 1-325) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 (AA 1-325) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| Recombinant PEG10 抗体 | 人, 小鼠, 大鼠 | 兔 Monoclonal |
|
|
|
| PEG10 抗体 (AA 325-375) | 人 | 兔 Polyclonal |
|
|
|
| PEG10 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PEG10 抗体 | 人, 小鼠, 兔, Pig | 小鼠 Monoclonal |
|
|
|
| PEG10 抗体 | 人 | 小鼠 Monoclonal |
|
|
|
| PEG10 抗体 (AA 1-120) | 人 | 小鼠 Monoclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 301-400
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 301-400
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 1-30
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-30
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-30
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 1-30
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 1-30
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-30
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗原表位
- AA 1-30
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 1-325
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 1-325
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 1-325
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人, 小鼠, 大鼠
- 宿主
- 兔
- 克隆形成能力
- Monoclonal
- 克隆
- A675
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
Primary Antibody
- IP (Immunoprecipitation: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 325-375
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 1B1C4
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- AA 1-120
Latest Publications for our PEG10 抗体
: "ONECUT2 is a targetable master regulator of lethal prostate cancer that suppresses the androgen axis." in: Nature medicine, Vol. 24, Issue 12, pp. 1887-1898, (2019) (PubMed).
: "DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation." in: Nucleic acids research, Vol. 47, Issue 17, pp. 9087-9103, (2019) (PubMed).
: "PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer." in: Journal of experimental & clinical cancer research : CR, Vol. 36, Issue 1, pp. 30, (2017) (PubMed).
: "miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma." in: Journal of translational medicine, Vol. 14, Issue 1, pp. 200, (2016) (PubMed).
: "uORFs, reinitiation and alternative translation start sites in human mRNAs." in: FEBS letters, Vol. 582, Issue 9, pp. 1293-7, (2008) (PubMed).
: "PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma." in: FEBS letters, Vol. 582, Issue 18, pp. 2793-8, (2008) (PubMed).
: "Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells." in: Oncogene, Vol. 26, Issue 39, pp. 5741-51, (2007) (PubMed).
: "DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation." in: Nucleic acids research, Vol. 47, Issue 17, pp. 9087-9103, (2019) (PubMed).
: "PEG10 overexpression induced by E2F-1 promotes cell proliferation, migration, and invasion in pancreatic cancer." in: Journal of experimental & clinical cancer research : CR, Vol. 36, Issue 1, pp. 30, (2017) (PubMed).
: "miR-122-mediated translational repression of PEG10 and its suppression in human hepatocellular carcinoma." in: Journal of translational medicine, Vol. 14, Issue 1, pp. 200, (2016) (PubMed).
: "uORFs, reinitiation and alternative translation start sites in human mRNAs." in: FEBS letters, Vol. 582, Issue 9, pp. 1293-7, (2008) (PubMed).
: "PEG10 directly regulated by E2Fs might have a role in the development of hepatocellular carcinoma." in: FEBS letters, Vol. 582, Issue 18, pp. 2793-8, (2008) (PubMed).
: "Androgen activates PEG10 to promote carcinogenesis in hepatic cancer cells." in: Oncogene, Vol. 26, Issue 39, pp. 5741-51, (2007) (PubMed).
Aliases for PEG10 抗体
paternally expressed 10 (PEG10) 抗体paternally expressed 10 (Peg10) 抗体
AA407948 抗体
EDR 抗体
Edr 抗体
HB-1 抗体
Mar2 抗体
Mart2 抗体
MEF3L 抗体
MyEF-3 抗体
RGAG3 抗体
您还需要查找其他产品吗？
You are here:
